Podcasts about ldi

Dr. Deb Muth 0:05What if your immune system isn’t broken, it’s just confused? What if chronic Lyme, the autoimmune condition, the food sensitivities, the exhaustion that never lifts what if those aren’t separate problems but one problem? A misfiring immune system that nobody taught how to stand down. Today’s guest has spent over 15 years doing exactly that, retraining the immune system from the inside out with a therapy so precise, so safe, and so effective that it has changed the lives of thousands of people who’d been written off by conventional medicine. Stay with me. This one changes everything.Welcome back to Let’s Talk Wellness Now, the show where we pull back the curtain on chronic illness, challenge outdated medical thinking, and hand you the real tools to heal from the inside out. I’m Dr. Deb, integrative and functional medicine practitioner, medical detective, and your straight-talking guide through the world of root cause medicine. Today, we’re going to dive deep into the immune system, specifically something called low-dose immunotherapy or LDI, and also into some hormones, chronic fatigue, and what it actually looks like to treat the cause instead of suppressing the symptoms. If you or someone you love has been told there’s nothing more we can do, this episode was made for you. Grab your cup of coffee, Settle in and let’s get to work. Now, before we bring in today’s guest, a quick word from our sponsor, and then we are diving straight in. I promise. Did you know sweating can literally heal your cells? Infrared saunas don’t just relax you, they detox your body, balance hormones, and boost mitochondrial energy. I’m obsessed with my HealthTech Sauna, and right now you can save $500 with my code at healthtechhealth.com/dr-muth-req-25.I want to start you with a story because this is one I’ve heard hundreds of times in my own practice, and I’m guessing you’ve either lived it or know someone who has. She’s 42. She’s been sick for years. Fatigue that doesn’t lift with sleep, joint pain that migrates, brain fog so thick she can’t finish a sentence, and a gut that seems to react to everything she eats. She’s been to her GP, rheumatologist, gastroenterologist, maybe even an immunologist, and every single lab comes back within quote unquote normal limits. She’s handed a prescription for something to manage the symptoms and sent home. Maybe she’s been told it’s anxiety. Maybe she’s been told it’s aging, or maybe and this one always breaks my heart she’s told it’s all in her head. That woman is not imagining it. She is not anxious and she’s not aging poorly. Her immune system has lost its ability to tolerate things it’s supposed to tolerate, and no one has offered her the therapy that could actually fix that. And what we’re talking about today with my guest has been practicing integrative medicine for over 15 years. Ty Vincent holds a medical degree from the University of Washington. He completed his family medicine residency in Anchorage, Alaska, and since has built one of the most impressive clinical repertoires I’ve seen anywhere in this field: acupuncture, Chinese medicine, environmental medicine, bioidentical hormones, hyperbaric medicine, chelation, regenerative peptide therapy, psychedelic-assisted therapy, and nutritional medicine.He lives and practices on the Big Island of Hawaii. He is married has 9 children. Oh my gosh, 9! And he has personally navigated type 1 diabetes, which, as you’ll hear, is not separate from his mission. It actually is his mission. And most importantly, he is a world authority on low-dose immunotherapy, a therapy he pioneered in 2008 and since has trained over 200 providers globally and changed the course of chronic illness care as we know it. I have had the pleasure of learning from Dr. Ty Vincent. I have had pleasure of taking his low-dose immunotherapy course when he first started back in like 2008 or 2009. I remember doing it back then and learning more about it in 2011. And this is going to be a great conversation for us. So one quick ask that I have for you guys, if this sounds like something that you want to learn more about and you’ve listened to some of our shows, please share like, subscribe. It means a lot. It helps us grow our channel. It helps us continue to provide for you different topics, different speakers, and really give you what it is that you’re looking for.So without further ado, I’d like to introduce you to Dr. Ty Vincent. All right, so Dr. Ty Vincent, this is gonna be a great conversation. We were just chatting before we went live of my training with you guys way back in like 2015, and I’m excited to hear all the new things that you’ve got going on. But introduce yourself to the audience. Tell us a little bit about you, how you got involved in this, uh, where you’re at, all that good stuff. Tyvincent 5:29Okay. I, uh, it’s a long story, but some of the highlights, I guess I was born in Alaska in the early ’70s and grew up there kind of wandering around in the woods with my dogs with no one around all day long. It was amazing. You don’t get kids don’t get that experience anymore. So you kind of learn to be an independent thinker, I think, you know, because latchkey kid, parents weren’t home till 6 and you’re on your own from early. Dr. Deb Muth 5:49That was a great time, wasn’t it? Yeah. Tyvincent 5:51I mean, I have, I have 9 children now and none of them grew up like me. And despite my effort, I mean, I’d have to basically like helicopter them out in the woods and drop them off for a few hours for them to understand what independent kids today are so dependent and parents are so helicopter that, uh, it’s changed. Anyway, I, I grew up just really liking science and really loving science, a huge nerd. And, um, and, uh, when I went into college, when I wanted to be a marine biologist and I thought that that was my passion of the ocean wildlife and all that, and then halfway through college, personal Couple things made me change my mind. It was a girl, you know, the usual. And I decided to go to school in Anchorage instead of going I was, I was transferring to Hawaii and I was going to study marine biology. And then, uh, my girlfriend moved back to Alaska where we were from. And I decided to do that instead. And then they didn’t have a marine science program.So I decided I’ll just get a biology degree and go to medical school. I’m a smart guy. I can do that, but I had no awareness of medicine. I really didn’t have any, you know, the passion some people have to be a healer and to go help people wasn’t part of the calculus at all for me. I was kind of an Asperger’s kid, so that really wasn’t the way I thought, honestly. And then I went into medicine and I was really interested in the science, the biology, the biochemistry, all the stuff, the physiology. And before I started medical school, I was reading some Andrew Weil’s books and I was, I decided to get a book on nutritional biochemistry because I naively thought that’s what they were going to teach me, right? This is how you make people healthy. You figure out how it works and you give them the things that make their body work right. Yeah. And we all know that that’s. Not been true for over 100 years now since the Flexner Report. And, you know, the rich people steered the government towards pharmaceuticals. Dr. Deb Muth 7:26Yeah. Tyvincent 7:26But that was my interest. And when I went through the first 2 years of medical school, I just really devoured all of the basic science stuff. And that was what I thought was the most important. And I honestly mastered all that. I scored in the top 1% in the country on all the exams and everything. And it was the top, in the top of my class at the University of Washington. And then you start doing clinical medical training and you discover that they don’t use any of that knowledge anymore, really, unless it pertains directly to pharmaceuticals, and that pharmaceutical research is extremely narrow and reductionist, and they only want to try to prove one little effect, and it doesn’t translate to real health. So as I got into clinical work and started residency, you know, by the third year of residency, I was like, they didn’t really teach me how to help people with chronic illness. You know, I was, I went to family medicine residency, so I was delivering babies.I was assisting with surgeries. I was in the ER. I was doing colonoscopies. I actually did colonoscopies in practice after residency, which family Doctors almost never get to do, but I’m a small town in Alaska. So I managed my own ICU patients and did everything, literally circumcisions in the office. And you’re dealing with like hospice and end of life care, just both ends, right? Pregnancy to death. And so I’d realized that if I really wanted to do the job well, which was my goal, I needed to learn other things. And in my, in my third year of residency, I actually did the extra, like, like additional training in medical acupuncture that was put on by the Helms Medical Institute then with Joseph Helms.And that was great. And I had to learn Chinese medical theory and I learned, I did the extra module on Chinese herbal medicine. And it was wonderful because I had to open my mind to a completely different way to evaluate people and illness. And I thought, okay, well then there’s got to be more. And as I went, I just became this voracious consumer of broad medical knowledge, not conventional medicine. You notice how a lot of the conventional people call it traditional medicine? Dr. Deb Muth 9:07Yes. Tyvincent 9:07Which annoys the crap out of me because there’s nothing traditional about something that’s been around for 100 years. I mean, you need time, you need like an epoch to say something’s traditional. But they’re like, no, I’m like, and then we were considered alternative medicine minded and everything like, oh, well, Well, it’s an alternative to real medicine. The vernacular in our culture really dictates thinking, unfortunately. I went on to learn functional medicine. So like 2005, I did the acupuncture training. 2006, I found the IFM and I read their entire textbook in a few months. And I went to the trainings. I was like, okay, now I know what you guys have to teach me. And then I found a bioidentical hormone therapy training course that was like Jonathan Wright and Terry Hertog. Dr. Deb Muth 9:46Terry Hertog, yes. My favorite guys. Tyvincent 9:49They were great. Dr. Deb Muth 9:50Pioneers, right? Tyvincent 9:51Yeah, exactly. And, you know, I learned what their opinions were and all that. And then you don’t really learn how to use a tool or you don’t get really get facile with something until you are using it and you’re applying it to your patients. And I went beyond that. I learned all kinds of IV nutrition. I learned chelation therapy. I joined the Environmental Medicine Academy and I learned how to do various forms of immunotherapy, eventually leading to learning LDA, low dose allergy therapy, through them in 2008. And for those of you listeners who don’t know about low-dose allergy therapy, when you learn about it, basically it’s like homeopathic dilutions of antigens.But instead of single antigens, like if you go to that regular allergist, they’ll just prick test you, blood test you, whatever, and say, oh, you react to mold, you react to chicken, you react to your husband’s whatever. They don’t test for that. I sometimes do. And they’re very narrow-minded about it. And it’s like you just give the antigens that the person tested for and you’re always missing something. With LDA, you get these huge broad mixtures of antigens, like for foods, it’s just hundreds of foods compiled into one for environmental allergens. And the reason you can get away with it is that the dilution factor is so far out. There’s no physical interaction with the body and you can’t, there’s no risk of inducing allergy, right? Whereas conventional shots might be 1,000 to 1, 100 to 1 dilution. We’re out at like a billion to 1 or further in most of these. And it sounded like nonsense to me, right? Despite all of my training I’d already had and all these things and being open-minded, it still sounded ridiculous. Pointless, right?But at least I was willing to give it a try because I had patients in my clinic, my family medicine clinic in Alaska, that had horrific allergies. Just like kids with eczema from head to toe. They look like they’ve been set on fire. Half their hair wouldn’t grow out of their head. They’re just miserable. They won’t grow. They’re on steroids. And I just thought, if there’s if this has any chance of working for these kids, I’m going to give it a try. Plus, two of my kids at the time had eczema, like persistent eczema that was really annoying. And I kids with eczema is a near and dear thing to me now. I like, I get emotional treating these kids, but, but that’s because it’s miserable for the families. Right. So I took it hard and I started treating my kids and, and, uh, kids in my clinic with LDA and it worked like magic because magic is just science we haven’t figured out yet. Right. We just, you know, some, but it was undeniable that it was working incredibly well. And then I was like, well, what is going on here? How does this work? And you learn the whole history of it. It goes back to the 1950s. I’m like, but, but it’s still so limited. There’s so much more as you start to treat patients with every tool in your toolbox, you run into these walls occasionally where you’re like, okay, everything I’m doing now isn’t working. And this patient has some kind of chronic inflammation, which is a very general term.People go, I have inflammation. Yeah, yeah. What we all do every day, all the time. But they would have these chronic inflammatory disorders that really seem to be immune driven. And then I thought, well, in terms of understanding low-dose allergy therapy, if I can identify what the target antigen really is that’s underlying this patient’s condition, and I can restore tolerance to that, which is basically how LDA works, then you could resolve it. And so I set about experimenting with all kinds of autoimmune disorders. I mean, at the time, LDA and the predecessor therapy called EPD, they had a few bacterial antigens, and we knew that there were connections between like rheumatoid arthritis and the bacterium Proteus. So that was in one. Klebsiella was the target antigen for ankylosing spondylitis. I’m thinking, well then, what about all these other autoimmune disorders? So I started just treating people creatively and trying all kinds of different things. Luckily, I had a contact in Orange County who had a warehouse, like a biomedical sample warehouse, and he was willing to give me antigen mixtures almost anything you could imagine in the biomedical world.The first thing I had him put together was Candida. I found those of us in the medicine space realize that some people have this huge problem with Candida. The conventional medical world thinks, well, yeah, everybody’s got Candida. That’s not a thing unless it’s an infection, blah, blah, blah. But you see these patients that are super ill, persistently ill, and you give them antifungals because you think, okay, well, you have these red rashes and itching and constipation and fatigue and muscle pain, blah, blah, whatever. It sounds like a yeast problem. Some of them, interestingly, if you do stool analysis, they show no yeast on their stool, which is a clue to me with a different thinking process that the reason the yeast isn’t growing in their stool is their immune system must be attacking it and killing it off in the gut, right? Because who doesn’t carry Candida? So the, the tests that run those are the stool company the test the companies that run the stool test, they don’t flag that result as abnormal because, yay, good, you have no yeast. But it’s horribly abnormal, right? Like if you saw somebody with no, no ears, you’re like, that’s not right. And so I thought, well, maybe they’re immunologically hypersensitive Candida. And so I, I was able to purchase a mixture of Candida species. And it occurred to me that I should include Saccharomyces cerevisiae in there because baker’s yeast and brewer’s yeast, people become sensitive to that too.So I made this and some of the patients that I was seeing where I would put them on Diflucan and Nystatin and all their symptoms would just evaporate, right? But you try to stop the medications after a month or whatever, and within 48 to 72 hours, their symptoms are right back. And that was one of the things, another clue to me, like, well, then that’s not an infection. I mean, they’re not taking antibiotics. They’re not eating a ton of sugar. Why would this regrow? And one of my criticisms of our integrative medicine world is we have just as many fairy tales and dogmatic beliefs as the conventional medical world. They’re just more colorful. Dr. Deb Muth 14:59That is true. That is very true. Yeah. Tyvincent 15:01And people were saying, oh, well, it’s because Candida lurks and hides in these nooks and crannies and corners in your body. And I’m like, I’ve done colonoscopies for years. I don’t know what you’re talking about. Like, it’s sparkling clean in there after some Go Lightly or whatever you torture your patient with the day before a colonoscopy. I was like, well, that doesn’t make sense. And they’re like, well, it’s because Candida uses mercury as a weapon to fight off your immune system. I’m like, you’re anthropomorphizing this organism as if it had agency to make tools, right? It doesn’t make sense. So then I came up with this idea to desensitize people to Candida. And it was incredibly effective.These patients, when you find the right dilution, you know, and for those who don’t know, it’s just a couple of drops of water put under your tongue, taken out of a syringe from multiple different dilution steps of the mixture, whether they’re using, right? So these people would respond. Most things I’ve developed, people respond. Somewhere near a trillion to one mathematically. And it was incredible. And I was like, okay, this is something that I’m sure relates to other chronic illness problems. And I started experimenting with I had a couple of patients with inflammatory bowel disease, ulcerative colitis, both of them early on. That was 2009. And I was like, well, they didn’t respond to the yeast mixture. They didn’t respond to the food mixture. And I was like, well, they’re reacting to something.And presumably that something is living in their gut. Right? I now know people react to different bacteria. There’s a ton of different bacteria and other organisms in your stool. So I came up with the crazy idea after seeing Dr. Bill Ray at an environmental medicine meeting talk about what he called autologous vaccines. Dr. Deb Muth 16:29Right? Tyvincent 16:30And I want to be clear, the way a vaccine works is probably the total opposite of how LDA works. It’s not the same thing. You’re restoring tolerance with LDA, LDI, and you’re promoting a robust immune reaction to a target antigen with a vaccine. At least that’s the theory. And now I’m not. It’s true. But Dr. Ray was talking about that and I thought, well, that’s a cool idea. And I went up and I asked him like, how do you do this?How do you make these things? And he kind of gave me like a very brief, you know, brush off. He didn’t know me very well. He’s like, oh, you get these Millipore filters, these little things you put on a syringe and you can dilute something and pass it through into a vial and it’ll be a sterile solution and you can dilute it. I was like, oh, great. So I collected one of my ulcerative colitis patients’ stool who was having at the time like 12 bloody bowel movements per day, every day. He’d seen all the conventional gastroenterologists. He tried the different drugs. They weren’t working. He went to some really special integrative greater clinic in California that primarily dealt with gastrointestinal disorders, and he did everything they wanted him to do, and it also didn’t help.I did discover that he was sensitive to gluten, and when he went off gluten, his, his gut still didn’t improve. So I made this autologous stool, um, LDA I called it then, which now I change it to LDI because LDA is a proprietary term and it’s also very narrow in scope. And I gave him doses and looked like the second dilution maybe that I went through hit. Literally his, his diarrhea and bleeding stopped overnight. And by 3 days he was having completely normal stools and no pain, nothing. And that taught me a couple of things. One, this theory works, right? And two, you know, we talk about the concept of leaky gut in the alternative medicine world, like integrative medicine world, sorry, a lot.And I’m like, yeah, but that’s not a diagnosis. That’s a symptom. You know, you still figure out what’s causing inflammation. And people are like, I just have leaky gut. It’s chronic. And you know, what do you do? And what I found was if you just put the fire out, the house rebuilds itself. Health very quickly. You know, we know that the lining of the gut turns over extremely fast. That’s why it is one of the first things to go when you do chemotherapy. And these people were basically healed to normal within less than a week. Same thing with kids with eczema that had these horrible oozing, weeping skin patches. Dr. Deb Muth 18:25I would. Tyvincent 18:25Or psoriasis even. When I developed some things that would treat psoriasis later on, you, you give this person with just, you know, deforming sort of rashes the right antigen, within 3 to 5 days they have normal looking skin except for maybe residual depigmentation or scarring if but it just blew me away. Dr. Deb Muth 18:42That’s crazy. 3 Days. Tyvincent 18:44The key to solving these problems was to restore immunological tolerance for the thing that it had lost tolerance for. Dr. Deb Muth 18:50Right. Tyvincent 18:50And it just really made me think about everything we were taught about chronic illness and everything we’re taught about the immune system in a very different way. And so since 2009, I’ve developed I’ve continued to develop new mixtures for new things because I run into patients. I can treat so many more things now highly successfully than I could before, but there’s still always the failures. People would ask me over the years, you know, why did you pick up all these skill sets?Like I learned acupuncture and Chinese medicine. I learned bio I became a Reiki master even, because I’m like, well, energy is a thing too. And so I get into the energy medicine world and that also works. And especially if you add it to acupuncture, it’s a great combination. All this stuff. And I would still fail. And I, it occurred to me when people ask me the question, like, I’m driven by failure. I really don’t like it. And I said, uh, and I thought that was how everybody believed, you know what everybody thought, right? But then you when you study our conventional medical colleagues and a lot of our people in the integrative medicine world too, that are doing the same things, the same protocols.And I hate the word protocol because it’s a poor substitute for thinking, right? It’s so that you don’t have to think here, follow this list, but everybody’s so different. So I never developed a protocol for anything to this day. I don’t, that’s not what I do. I was like, despite all of this, their patients aren’t getting better either. And it’s like, well then, you know, just philosophically, which I was a big philosophy student in college too. I thought if, if what you’re doing doesn’t work, do something different, you know, make new mistakes, figure things out. And I just got really creative. And by now I have, my gosh, I have 100 different kinds of antigen mixtures. And to be very honest, half of them have never worked for anything because that’s how it works, right? You got to. Dr. Deb Muth 20:17You’re trying it. Geez. Yeah. Tyvincent 20:19You’ve got to be willing to be wrong if you ever want to be right. One of the things I’ve noticed about humans in general is they’re very unwilling to see when they’re wrong because it’s emotionally painful to let go of something that has maybe been a part of your self-identity or especially like when you get experts in a field and they’re famous for some theory or treatment or whatever they developed, even if evidence shows up later, which it inevitably does, to show that what they’re doing isn’t complete, maybe not wrong, but not complete, there’s huge resistance, right, to the change. Dr. Deb Muth 20:49No one will admit that there’s something that didn’t work initially when they thought it did. Tyvincent 20:54Right. And nobody wants to admit I’ve been doing something wrong or ineffective or less than it could be for 20 years. You know, that’s unsettling. But to me, I’m like, well, isn’t it worse to keep doing it wrong? Right? Dr. Deb Muth 21:06That’s the whole idea. Like, right? We’re supposed to be bettering ourselves. Medicine’s supposed to be adapting and changing, and we don’t. Like, there’s a lot of things that we still do the same way we did in the 1950s and ’60s. Cancer treatment is one of them, right? We don’t really do anything different than we did back then. And when you look at precision medicine, we have all these new tools, but people stay stuck in their way of doing things just because maybe it’s easier, they’re comfortable or whatever. It doesn’t always make it the best interest for the client. Tyvincent 21:36No. And that is the goal we all need to keep in mind. Dr. Deb Muth 21:38Yeah. Tyvincent 21:39What I thought was like the job is to fix the problem the person has. And if the tools you currently have don’t do that, you need to learn something else. Dr. Deb Muth 21:48Yeah. Tyvincent 21:48And eventually I got a little saturated with learning new things. Dr. Deb Muth 21:51I’ve been there. Tyvincent 21:54Turns out there’s a limit. You know, we use the term drinking from the fire hose for everybody who like comes, like conventionally trained doctors who first get into the integrative medicine world. You’re just like, what are you talking about? It’s all so foreign and new. And then you have to use it and realize, okay, there’s, there’s a lot of truth here. But I got to a point where it’s like, I just don’t have the time in my day to use every tool. Like I bought an Indigo machine. I don’t know if you’ve heard of it. So the old EAV technology from Germany long ago, electrodiagnostic things and Then they developed computer programs and software that could analyze 11,000 different frequencies. It’s all energy frequency based. And I bought one of these for like $25,000. I still have it in the case collecting dust because I just didn’t have time to learn how to use the tool. And I was like, all right, I got to just get really, really good at some things and then let my colleagues who are good at other things help people with the things I can’t treat and I’ll tell them where to go. You know, it’s a collective, it’s a team effort. Dr. Deb Muth 22:47Right. It’s got to be a team effort. I’m curious what you’re finding these days with the newfound for mass cell, right? MCAS, everybody’s problem child, and nobody has a good answer. And it’s, it’s an immune reaction, right? It’s not just that I’m allergic to everything situation. Back in the day, 20 years ago, you and I would have called these the chemically sensitive people, and now we at least understand what’s going on. It’s an immune reaction. But I’m curious what you’re finding with LDI and that population of people. Tyvincent 23:19It’s a really good question. I know, I know you’ve had other interviews where people have discussed it philosophically to start the conversation. I really have found over the years that a diagnosis is the least helpful thing you can give your patient. Dr. Deb Muth 23:31Agreed. Tyvincent 23:31But we love labels. We love names. And we, and the problem is when you give something a name that does not reflect what’s actually going on, it just leads everybody’s brain in the wrong direction. And so there’s nothing wrong with these people’s mast cells. And that’s why I’m like, I despise the term mast cell activation disorder, but It is okay that they may be the end of the line releasing histamine and whatever, but a lot of these people have tons of inflammatory symptoms that have nothing to do with histamine, right? There are lots of mechanisms in the immune system that can give you cell-mediated inflammation or humoral, like antibody-mediated inflammation, different things. And mast cells are kind of an IgE thing, but it’s way more complicated than that.And when you work with these people, because a lot of them have found me because they have a very difficult time finding answers and solutions. I’ve been at most of us in this field have been at the bottom of a funnel where the options decrease because you try more and more therapies and they don’t work and the desperation increases kind of inversely proportionally. And then they’re trying weirder and weirder things that like people think are bizarre, you know, like you can eventually sting yourself with 20 bees a day, do apitherapy or something. Dr. Deb Muth 24:36I remember that therapy. And you know, as a practitioner too, it becomes more and more frustrating because it’s like, I’m trying all these things and nothing is working. What am I missing? And you keep trying different things until they just give up on you or you give up on them or whatever ends up happening, you know. Tyvincent 24:52Right. But again, like philosophically, every failure should lead you a step closer to success. Dr. Deb Muth 24:58Yeah. Tyvincent 24:58If you can look at it and you can learn from it what is possible from it and go, okay, I got to do this different or change this, or perhaps my entire theory about this problem is just dead wrong. Yeah. So if what I think is happening isn’t what’s happening, what else could be happening? And then you, you know, you come up with a theory and then you have to devise a way to test test it. And so like a lot of people probably tossed around theories about things being immune related or whatever over the years because it becomes a little obvious at a certain point, but they didn’t have a tool to test the theory.So that was the, the unique position I found myself in from 2009 onward was I’ve got a way to test this if I can figure out what antigen to try. And so I got a lot of mast cell people with that diagnosis. And, you know, my assessment of the problem is that when they come into my office, because like you and like most of people that are kind made it a little further in the integrative medicine world. The patients that find you have already seen 20 of your colleagues at the Mayo Clinic and the Cleveland Clinic and Germany, like Mexico, whatever. They’ve had exosomes infused up their nose or whatever. Like, all right, so what has not been explored yet? And you got to realize, okay, these, these people are there’s something going on. It’s very inflammatory. It’s probably immune related, but where is it coming from? Again, you mentioned root cause. You’ve got to trace the steps backward and try to figure out where is the point of intervention that will actually work and that’s feasible. And so what I found in these people, most of them have a pretty common early story of having had one or a few immune reactions that first began the process. And they might’ve been fairly benign and not that big of a deal.And then they go through some kind of immunological stress, whether it’s, well, some kind of stress, whether it’s a direct immune stress, like a vaccination or an infection or something like that. Like with COVID I’ve had an equal number of people who developed chronic immunological disorders after having the virus infection or having the vaccine. And the things that develop are virtually identical. So people are like, I should be gotten the vaccine. I’m like, it really doesn’t make any difference. Dr. Deb Muth 26:53Right. And I’ve seen the same thing with the HPV vaccine too. Like a lot of young people, they get that and all of a sudden their whole system is torn off after that. It’s very common. Tyvincent 27:03Except in that example, just getting HPV doesn’t do it. It’s the vaccine that does it. Dr. Deb Muth 27:07Vaccine that does it. Yes, exactly. Tyvincent 27:10Because everybody’s got HPV, you know, some other, and that is not in and of itself enough of an inflammatory trigger to lead to these chronic illness, right? You can lead to cancer, sure. Which is focal and it’s not a hypersensitivity problem. It’s a failure of immune defense problem. It’s a little different. So I would get these people and I’m like, okay, what happened first? What’s the beginning of the story? Because if you talk to them about how they’re feeling today, and a lot of your listeners, this will resonate with them. If I ask you how you’re doing today, the real cause of your problem is buried under a snowstorm of constant inflammation and your life experience is utter hell. And you have no clue what’s really triggering anything anymore. It’s like at a certain point, the immune system has developed PTSD, right? It’s just, it’s hypervigilant. Anything you give these people to take, even like vitamin C or whatever, then they go, ah, it made me worse.Ah, it made me worse. Because their immune system is now seeing anything foreign as an invader, as an enemy. So if you ask people just about how they’re doing today, you get absolutely nowhere. With these people. The one theory I had though was, well, maybe they’re reacting to histamine itself. Okay. I think is a beautiful theory. Makes total sense. Didn’t work at all. Spoiler alert. It’s not that it doesn’t work. It’s easy to get a sample of histamine, you know, and I also, I also got histidine, the amino acid from which it’s derived. I’ll say I’ll just put them together. So at least I want to say 12 years ago, I made like a histamine histidine LDI and everyone who had kind of the mast cell picture portfolio of illnesses, I would try it on. It has to this day, it’s never worked for anybody that I’ve tried it on. And I haven’t had another LDI practitioner tell me that it did. But again, that failure made me think about it in a different way. And so the success I’ve had with that population is not monolithic. It’s not one part. From an LDI perspective, figuring out what it is that they began to react to first, like, did you still have, do you have food problems originally?Oh yeah, I was kind of sensitive to gluten, but I just ate it anyway because I would just get some diarrhea and some, okay, it it was, it was livable, right? But they just keep exposing themselves to this trigger. And eventually something snaps in their immune system. Like they live in a moldy dorm room for 6 months and that all of that immune activation will kick off whole new immune response problems. And the world of mold is another area where I think people don’t, do not really understand what’s going on. And a lot of our treatment approaches don’t work for a large portion of these people. And it has to be kind of thought of in a broader sense. They could go through a divorce. They could have a car accident. They could have a surgery. A woman could have a baby, which is one of the biggest immunological triggers, unfortunately, is having a baby or early pregnancy miscarriage even is enough to do. Emotionally stressful. It’s physically stressful. It’s immunologically stressful.And then it swings your estrogen back up and you get this hypersensitive profile. But so all of these, what I call catalytic events were common in these people. And it’s not just one, it’s any one of them. And what I found was if I could identify what their initial triggers were categorically, right? Environmental things, chemical things, food. And if I could desensitize them to those, everything would settle down. And, and that was, that’s been the key to working with those people. But they want to tell you how horrible their life is today. Dr. Deb Muth 30:17Yeah. Tyvincent 30:17And you got to listen to that because you need the connection. You need to understand what they’re dealing with. You need to understand what their baseline is so that you can compare going forward. But the answers, the solutions aren’t in that story. And the solutions are in the history. And like, what’s the first thing you remember? And all this, like, okay, well, let’s go with foods. Let’s go with chemicals, whatever. And if somebody has distinctly worst triggers, right? Because right now they react kind of to everything. Any foods that you absolutely don’t eat because they give you the absolute worst reaction pattern, right? Oh yeah, I can’t eat these things. They’re the worst. Okay, well, maybe we’ll start with those and you can use those foods as your test exposures to determine if the dose works each time. So that’s one of the things I’ve developed stylistically over the years is the use of a test exposure if we’re using an allergen extract so that you can confirm or deny whether the therapy worked, right? Because people will tell you, oh, I feel better.Turns out that’s not worth much. You really need like, I mean, And belief is a huge part of that. Placebo effect is a huge part of that. You want to find something relatively objective, you know, so will you still vomit when you have chicken? You know, cause that’s like, that’s pretty obvious. And then go with that, you know, or do you still get a rash when you put on a bandaid? I love it when people get rashes from contact cause they can show me pictures and it’s not subjective, turns out. But even those reactions can go away 100% with placebo doses. It’s fascinating how people respond to placebos. So anyway, I try to find like the root beginning allergens. And then a lot of these people also accumulate other target antigens as they go through their process of being ill. Their immune system is so upset and it’s, it’s also just blurry vision, right? It attacks anything. Angry dog on a chain. If you get close enough, it’ll bite you. It doesn’t care who you are. And that’s how their immune systems get.So finding the antigens that are root cause is key. But a lot of these people have developed over time total adrenal burnout. Out, right? Because they’re in state of chronic inflammation, everything. So I also found that I had to lean on my skill in bioidentical hormone therapy, which over all the years I’ve been in integrative medicine, the two major skill areas that gave me the best results in general were hormonal management and immunological modulation. I got so many of the prior failures I was able to solve with those two things. And so if I would support these people’s adrenal, like hormones, you know, DHEA, cortisol, to optimal levels, a lot of them, their symptoms would cut by half, number one. And you would have a little more clarity as to what their actual triggers were.So in a lot of these cases, I learned to start with that before I even decided what antigens to pick. You can kind of get the snowstorm to calm down. You can start to find the snowmen in the blizzard that you couldn’t see before with all the chaos. I was like, okay, now that you’re feeling better most of the time, you can tell that these chemicals bother you, that mold exposure bothers you, that whatever, and then you can target things But the other third kind of leg of the tripod that I found are the keys to success with our most complex patients is to address like the hormonal issue, the immunological issue, but the subconscious fear response, the subconscious stress response in them. Dr. Deb Muth 33:14Trauma. Tyvincent 33:15And I saw that you’ve also people, yeah, trauma and people have medical trauma, not just trauma from their illness itself, but trauma from seeing 12 doctors that treated them like they were a head case and ignored what’s going on. Dr. Deb Muth 33:25Of the medical community, right? Tyvincent 33:27Oh God, you know, like people— yeah, the more doctors you see, the more your trust in doctors goes down. Dr. Deb Muth 33:34Yes, exactly. Tyvincent 33:35They see one of us and some of them just automatically are like, whatever, here’s another failure coming my way, kind of thing, you know, realistic. Partly because it becomes too risky to have hope, right? Like after a while you’ve had hope, hope, and it’s been dashed, and you just can only handle that so many times. It’s like you fall in love and then they dump W. And after a while you’re like, I’m celibate. I don’t care anymore. Um, so you get these people and what we have found, my wife and I started doing psychedelic-assisted therapy with patients a few years back. In fact, this little cottage on my property we built specifically for that purpose. People can come and stay here for a couple of days.There’s a bedroom on the other side of this wall. And we do therapy with them. We have a very good process of getting their hormones tested before they come, trying to correct any deficiencies or imbalances, especially cortisol and DHEA. We try to make sure that if they have immune problems that seem manageable, we maybe try to control those first. But in a lot of these people, we have to get their subconscious fire alarm to go off first because anything new that enters into their sphere of existence is seen as this, you know, scary thing. Dr. Deb Muth 34:36Yeah. Tyvincent 34:36And so what we found is getting their subconscious to settle down, getting them to integrate past whatever trauma they’ve had so that it’s no longer causing harm today from an experience 20 years ago, right? Because that’s not fair. A lot of these people, all of their immune stuff stops and I don’t even have to do LDI. And that’s fascinating. And some of them, we put them on hormone replacement, everything calms down enough. It’s like one of these things sometimes works. And in other people, they need all three. And the trick in those people is to figure out what thread you have to pull on first. You know, it’s like, well, okay. And we spend a lot of time, my wife and I both work with patients together. She’s amazing. She’s not a trained clinical clinician. You know, she had a business degree, but she’s like, she tells people I attended the school of Dr. Ty Vincent for 10 years. Dr. Deb Muth 35:20Yes. Tyvincent 35:21Heard him say all this a million times. And when we first started seeing patients from home together, she read all of my patient notes and just great. So she. Dr. Deb Muth 35:28Yeah, that’s how you learn. Tyvincent 35:30Yeah. And people like, well, I didn’t go she’s like, I didn’t go to medical school. I’m like, that’s an asset, trust me. Dr. Deb Muth (35:34-35:40)Exactly. Oh my God, you haven’t been brainwashed. Exactly. Tyvincent 35:40And you know, it’s not even so much washing as it is like throwing mud all over the walls. All of these false beliefs you’re given, and, you know, not just the beliefs, but the disbeliefs, both of those hold people back. And I was like, it’s your disbeliefs that are the bigger problem because you don’t even realize they’re there. Like when I learned about LDA, I’m like, that’s nonsense. No, it’s not. Dr. Deb Muth 36:02I’m curious, when you treat some of these complex people with LDI, are you using multiple modalities at one time, or are you being really cautious with them and using one at a time? Time, because some of them won’t let you do more than one thing at a time with them. Tyvincent 36:16And so by modalities, you mean like, are we also doing hormone therapy? Are they also doing like IV, like other things? Or you mean multiple antigens within? Dr. Deb Muth 36:24Multiple antigens, yeah. Tyvincent 36:25Um, it really depends. And early on, so I everything I know about LDI, I learned through experience, paying attention, putting connecting dots over you. And it’s been been a very long process, right? Early on, like a kid in a candy store, you see a patient and you find out, oh, they’re allergic to some foods, they’re allergic to some chemicals, they’re allergic to cats and birch tree pollen, and they also have psoriasis or whatever. And you’re like, ooh, I’m going to give you all 4 of these antigen mixtures because you have all 4 of these issues. And by 6 months in, if you’re paying attention, you are completely confused and lost. Dr. Deb Muth 37:03Yeah. Tyvincent 37:04I did that for a number of years and I thought, well, this will be the fastest way to figure things out. It turns out it’s not, unfortunately. Um, what I’ve found is more successful is if I can figure out either what the most important underlying immune reaction is for them that might be cascading into other problems, or you figure out what’s the easiest one to solve first. So if somebody has like the whole mast cell picture and they got all this stuff going on, but they say the biggest thing is I have horrible chemical reactions. I’m a tr I’m trapped in my home. I created an oasis of safety here, but I can’t go anywhere. Anyone who comes to my house has to go into the entryway and take all their clothes off and put on a jumpsuit, right? There are those people. I work with them. Dr. Deb Muth 37:40Oh yeah, I have those clients. Tyvincent 37:42They’re like, oh my God. Well, if we can fix that first, your world will open up a ton. Your fear will come down. Your immune response will come down. And so sometimes it’s a matter of which one seems the most important or which one seems easiest. Like, okay, the test exposures that they have are the most obvious and distinct. For foods and not chemicals or whatever. And the reactions people have to these different antigens can overlap tremendously or even look exactly the same, which is why you kind of need to use one at a time. Because if you’re trying to ride a bike and a motorcycle at the same time, it doesn’t go so well. Dr. Deb Muth 38:16Yeah. Tyvincent 38:16Like, let’s find where you do with where you respond to this one, and then we will have less stuff to deal with. We might have a little bit more clarity as to what you’re reacting to in other categories. And then you kind of go through them sequentially. But if I have somebody who’s not like just in a real state of immunological distress like that, and they go, yeah, I’m allergic to cats and I have a cat because I’ll never get rid of my cat. I don’t understand those people, but, but there are a lot of them. They love their cats. Dr. Deb Muth 38:43A lot of them. Yes. Tyvincent 38:44I’m like, okay, or dog, you know, I’ve had people that are horribly allergic to dogs and the dog still sleeps in bed with them every night. Dr. Deb Muth 38:50Okay. Tyvincent 38:51Um, they’ve got that, that’s very clear, very distinct. And it’s, and it’s like a rash or a runny nose. And then they also have have celiac disease, let’s say. Like, well, we can treat both of those at the same time because the symptoms are totally different. You have test exposures in both categories and you’re not so sick that you’re in a constant state of like trauma response where you can’t even pay attention to anything. Right. And so it’s kind of case by case. And my style is very, very individualized. Like I said, there’s never a protocol. It’s like, I got to talk to people for about I usually talk to people for about an hour. Yeah. More than isn’t really helpful. You know, like, in an hour of time, you’re, you’re kind of saturated with how much you can invest your bandwidth into this particular issue. Now, like, okay, I know where we’re going to start. I don’t know where we’re going to end up, but I know where we’re going to start. And so we encapsulate that and then go, let’s do this. And then everything you do teaches you more about what else you need to do.And it’s a process. I my ego used to be more tied to guessing correctly at the beginning about what was going to work work and to fixing things quickly. And over time I realized like your ego really has no place in the exam room. Like that is a very, very challenging thing for practitioners to try to figure out is how to get your ego out of this because it biases you intellectually, emotionally, and it’s a problem. And our medical colleagues probably have bigger egos than the average human in the population. Let’s be honest. Um, there’s something that comes with the years of study and the investment and the status you have, and it’s a challenge. But if you be like, I just need to be clear about what’s happening, what’s not happening, and you figure things out. And so I was able to have a much better success rate approaching things that way.And every time you put out one little fire for people, one kind of immune response, it, you, you get a better picture about what else is going on. And then eventually all their problems have stopped and you’re okay, cool. I guess we’re done. But it’s, it’s hard. And you do learn that there are still major gaps in your knowledge. And, and you asked earlier about new developments in LDI. And whatnot. And I could literally talk all day about the things that I’ve developed over the years, but I still keep making new antigens. So just last year in the area of food allergy, so like your Mast Cell people, a lot of them have food allergies that are a big part of the underlying problem, and this will be relevant to them. But what I found is a lot of the people who seem to clearly react to food, and I put food in quotes because most of what Americans eat isn’t food, right? It’s it’s at least it’s not just food, or it used to be food and now it’s not. It’s like Frankenfood, and it’s got chemicals in it. It has molecules that don’t exist in nature, so you can react to them.So I found some of these people that would say, oh, I react to processed food items horribly, but if I eat the whole foods, organic whole foods at home, I don’t react. And, um, some of those people will resolve those problems with the chemical LD mixture. So they’re reacting to chem with that. A lot of them will tell you, oh, I also react to perfume. Or gasoline or whatever. Dr. Deb Muth 41:46Yeah. Tyvincent 41:46Okay. And so you can use that and some of those cases will resolve, but a lot of them don’t. And I had increasing failures. Like I’ve been doing this long enough to see and observe that early on I had much better success with these antigen mixtures than over time. People are the pattern and the causes and the manifestations of illness today are evolving right before our eyes because of what we’ve done to our environment and our food and ourselves. So what I came to to sort of theorize about was that maybe some of these people are reacting to processed cooking oils, like seed oils, plant oils that are put into processed foods, right? Because they would tell me a couple of key cases gave me that insight. They would say, well, I still react to all these processed foods.I can’t eat at restaurants, and I’m still reacting horribly to sesame seeds, or I’m still reacting horribly to flax, or I’m still reacting horribly to, like, one of these other things we make processed seed oils from. Well, maybe they’re reacting to the oils. And when we made the food mixture, you use whole food samples, right? So you use like a, a ses like sesame seeds, or I use tahini paste because it’s easier to mix in water. But maybe the antigen, the target antigen, is something inside that that is not properly like, what’s the word I’m looking for properly given to the immune system, or, or like exposed, shown to the immune system, right, in the way that their immune system is reacting to it. Maybe it’s a molecule in there that when you use a whole food antigen is not adequately represented. It’s like, so an oil would do that.And I had actually already years ago realized that some people react to essential oils, like flower extracts or tea tree oil or lavender or whatever. Right. And so I made an essential oils mixture from plant oils from the doTERRA and the Young Living products. I had a couple of patients that were like distributors for these things. And I said, just take an empty vial and put one drop of every single product you have in it and just mail it to me. And they both did that. So I have this huge compendium of essential oils, and I would get people that would still react to oranges and lemons and citrus fruits despite the food mixture. And then the essential oils mixture would totally stop that reaction. So I’d already kind of proven that this was the case with some of those more aromatic oils, right? Now I was like, well, people are reacting to the processed cooking oils because when you take oils out of the plant, if you ever do this at home, they’re opaque and gooey and viscous. And then somehow it’s this really pretty homogeneous, clear liquid that doesn’t separate at all. It has no nothing you see in there.And then you got to wonder, how the hell did they do that? What did they do to make that? And there are all these chemical processes and heat and everything. I’m like, well, it just makes new molecules that your immune system has never seen before. So in May of 2025, I bought 18 different kinds of plant oils, and some of them are really pure, like carrot seed oil, cottonseed oil. But there’s peanut oil and avocado oil and olive oil and, you know, all the seeds and things we use in there. And I even have a video on our Facebook page and probably Instagram of me making this mixture in my kitchen.I was like, people are kind of interested how this works. And I just made it right there on camera because it’s really simple. I started using it in some of my failure cases that had really seemed like they had food allergy responses, but the food mixture didn’t work. And the first one was actually one of our employees who does our social media management. She had a 3-year-old son, I think, probably 2 years old when we started working with him, with really bad body-wide eczema, right? And he never really responded to the food mixture, essential oils, skin bacteria, skin fungi, yeast. I tried all the things that usually work. I’m like, it’s something. And so he made the oil mixture. He was they were the first one. I just sent the doses like, hey, let’s check it out. And I think he got for I started 6C for most things, which is a truly and then it’s like 5.5C, 5C. We got to 3.5C, I think, is where he is, which is a dilution of of 10 million to 1, I believe. And 95% of his eczema just completely went away. Dr. Deb Muth 45:38Wow. Tyvincent 45:39The only thing left was a couple of those patches on his feet. And one of the things I learned about people with eczema is they will have localized, like geographically local consistent reactions to different things. This is crazy, right? Dr. Deb Muth 45:53Yeah. Tyvincent 45:53Your immune system has kind of a, you know, like an overall regulatory system, but it also has regionalized systems, just like the government federal government, state government, county government, city government. It’s, it’s divided like that. So the people will eventually learn, oh, if I eat gluten, I get these itchy bumps on the side of my hand, and if I eat carrots, I get a rash on top of my head, you know. And it’s very, very clear once you identify it. So there’s still something that kid’s reacting to that I haven’t quite solved on his feet. But, um, yeah, that worked amazingly, and it actually made me cry when I got the pictures She’s like, oh, finally, after probably a year and a half of flailing, you know, we got it right. And so now I’ve been using the cooking oils mixture more and more and more. Just yesterday I got an email. I have a teenager, he’s 8, he’s maybe 18, 17, 18, with just really horrible cystic acne, painful, erupting. And the before pictures are just hard to look. I mean, he’s got horrible involvement of both sides of the face, the chest, all over his back, and you can just see the scarring and the redness and the inflammation.And we went through the food mixture with him and whatnot, and it really didn’t touch it. So yesterday I got the report. He got up to the cooking oil mixture at 2.5C, which is 10,000, 100,000 to 1, and, and his cystic acne stopped. Like, he’s getting zero new lesions. All the redness, pain, inflammation is gone, but he still has all this just scarring from it because that’s permanent, right? You have to get that repurposed. And all he has left is little tiny whitehead pimples, like maybe one new one per day here and there. You can see them now in the midst of all this. So acne is diversified. There are different kinds of acne and people can have more than one type and they can react to hormones. They can react like I’ve had guys with bad acne respond to desensitization with testosterone, for example, or women desensitizing them to estrogen or progesterone and the acne will go away sometimes. Some people respond to yeast, some people respond to skin bacteria, skin fungi. And so this is another thing. And my wife actually is one of the more complicated immunological cases I’ve ever had to work with. Working together for 10 years, um, you know, like the first time I saw her, she had Lyme disease and the Lyme LDI just totally stopped those symptoms like magic, which is great.That’s one of my favorite things to treat. Um, because the beliefs we have about Lyme disease, I have found completely untrue because using a different tool. I’m like, oh, it’s an immune problem, not an infection. So anyway, so that, that worked for her. Some of her food reactions went away, but she still continued to get like deep painful cysts if she would have nuts or dairy. And so the cooking oil mixture now, after 10 years of being together, totally stopped those reactions. Peanuts, nuts, dairy. And the dairy one is interesting to me because it’s not a plant oil, right? It’s an animal oil and it’s not represented. And we have dairy products in our other mixture. But I think what’s happening is when cows are fed grain, sometimes what an animal is eating carries through some essence or nature of that substance into the milk. Um, and the thing I’ve seen this the most clearly with is corn. Corn allergy is a very unique situation. The way people deal with it, the way it manifests, the way you have to treat it is different from every other energy. And I don’t have an hour to talk about that specifically, but I observed primarily with corn that anywhere along the food chain, you’ll still react to that food if the animal at the beginning was ever fed corn. Multiple I’ll have babies that get an eczema reaction or a GI reaction if mom eats corn-fed beef. But if mom eats grass-fed beef and then nurses the baby, they’re fine. Dr. Deb Muth 49:33Yeah, I’ve seen that too. Tyvincent 49:34It’s bizarre. Dr. Deb Muth 49:35Yeah. Tied. This has been really so amazing. Um, tell us how people can find you if, if this is resonating with them and they’re like, I need him to figure out the puzzle for me. How do they find you? Tyvincent 49:49So the best thing to do is to go to our website. Our, our business name is Global Immunotherapy, and the website is just http://www.globalimmunotherapy.com. We have, we have a much better website than we did years ago. People schedule directly through the website. Right? There’s all kinds of information. I’ve been making YouTube videos and informational videos for people for more than a decade now because nobody has any idea what I’m talking about. The more they understand it beforehand, one, they get to decide if they just think I’m crazy, right? And they don’t want to waste their time. And there are plenty of those people, but a lot end up talking to me 3 years later because after they’ve tried everybody else and there’s nothing left to try, right? Yeah, yeah, like being at the bottom of the desperation funnel. Yeah, people like, well, I heard about you 5 years ago and didn’t make sense. I’m like, yeah, cool. But then I had 3 or 4 other people over the years tell me I should talk to you. So here I am. That’s, that’s right. And people can watch all these educational instructional videos about how LDI works, what it can be used for. So the more you learn and understand what you’re getting into ahead of time, the less time we have to spend during our hour trying to explain to you the therapy., which to take up half the time and better results you’re going to get because you’re educated and it’s a partnership.Like all of us in the world of integrative medicine, one of the big differences between us and conventional medicine is we understand that it’s a partnership. You have to listen to the patient, you have to educate the patient, you have to engage them in their own health. You can’t just say, here, take this pill and come back in 3 months and I’ll check your labs again to see that you still have the same illness. It’s just and people have a lot of our population has been led to believe that just swallowing a pill is going to fix your problems. But That doesn’t work. And we have to develop a relationship and an understanding and shared knowledge and beliefs. And so people now, they have this opportunity to watch all the videos. And I really want people to do that before they ever schedule, because one, you’ll, you’ll feel like it’s the right therapy for you. And that helps a lot. Having optimism going in is super helpful. And then two, you already know a lot. So you’ll know more about what questions I might ask you and how to answer them. You’ll know more about about how the therapy works, and I won’t have to explain it to you, and we’ll get a better use of our time. And then people can schedule right through the website with either myself or my wife Jeanette. And anybody who Jeanette talks to, she reviews every case with me, and we work together with stuff. And, but in terms of like using LDI, she’s probably the second or third best practitioner in the world. I

In this episode of LIGHT TALK, The Lumen Brothers and Sister discuss everything from Rowing your Boat, to Becoming a Visual Storyteller. Join Ellen, Steve, and Dennis, as they discuss: Visiting the Asolo Theater; Dinner with Brother Stan; The Coxwain; LDI moving to New Orleans; The Four "C's" of lighting; How to survive a Lighting MFA program; The most important skill to have to be a successful professional lighting designer; and How to design a plot for a multi-purpose space. Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

Hosted by David Cowen | Careers and the Business of Law David Cowen sits down with Bobby Malhotra, litigation partner and chair of Winston's eDiscovery and Information Governance practice, member of the firm's AI strategy group, and founding member of Legal Data Intelligence. Bobby sits at the intersection of eDiscovery, digital forensics, cross-border data, privacy, cybersecurity, information governance, and AI governance, bringing a rare combination of legal judgment, technical fluency, and hands-on curiosity. This conversation covers why AI governance has arrived, why information governance is making a comeback, and why the next generation of legal professionals will need to become tech-and-data lawyers.   WHY THIS MATTERS? AI governance is no longer a future issue. It is already here. Companies are dealing with employee use of public AI tools, data exposure, privacy risk, cybersecurity concerns, regulatory pressure, AI policies, privilege questions, AI transcription, and AI-related incidents. For lawyers and legal professionals, this is one of the clearest career white spaces in the market. KEY TAKEAWAYS AI governance has arrived. It is already one of the hottest and busiest areas in the legal industry. AI governance is about vision, guardrails, policies, ethical obligations, legal obligations, regulatory compliance, and business risk. Information governance is the backbone of AI governance. You cannot govern AI if you do not know where your data lives. Data governance sits inside AI governance, and may be the most important part of the whole program. The legal role is expanding, not shrinking. AI governance and data governance are creating new career lanes across law firms, corporate legal departments, privacy, cybersecurity, eDiscovery, and legal operations. You do not need 20 years of AI governance experience. No one really has that. Curiosity, teachability, issue-spotting, and legal judgment matter more. The best professionals in this space combine legal thinking with technical literacy. It is not just about knowing the tools. It is about applying the law to the facts, the technology, and the risk. AI governance is not just about models anymore. It now includes privilege protection, AI transcription, employee AI usage, public AI tools, data exposure, and AI-related breach scenarios. Outside counsel and in-house teams both have a role. Some companies rely heavily on outside counsel, while others use outside counsel for strategy, policy review, sanity checks, regulatory guidance, and high-risk questions. If you want to build a career in this space, get comfortable being uncomfortable. Follow the law. Follow the technology. Find mentors. Set up news alerts. Stay close to communities like LDI and IAPP. PEOPLE MENTIONED David Cowen - Host Bobby Malhotra - Litigation Partner; Chair of eDiscovery and Information Governance; AI Strategy Group Member; Founding Member of Legal Data Intelligence Melanie Prevost - Referenced in connection with career creation and emerging opportunities Malcolm Gladwell - Referenced in connection with the 10,000-hour rule COMPANIES & ORGANIZATIONS MENTIONED Winston - Bobby's firm Legal Data Intelligence / LDI - Community and framework for legal data professionals IAPP - AI governance and privacy education resource CLOC, ILTA, SOLID - Legal operations, innovation, and business of law communities M365, SharePoint, cloud platforms, data lakes, and metadata - Referenced as examples of where organizational data lives Colorado, Connecticut, Illinois, California, and Texas - Referenced in connection with emerging AI legislation EU AI Act - Referenced in connection with AI regulatory obligations NAIC - Referenced in connection with AI guidance in the insurance industry New York DFS - Referenced in connection with regulated financial institutions

Just a quick update to our upcoming schedule. Long story short - The Outsiders is coming for members only as well as a watch of the film, Street Fighter from 1994. Yes, the JCVD one about the video game with Raul Julia. Additionally, we will be dropping Payback on the LDI feed next week. Stay tuned and if you just can't wait and want to support the show give membership a look! Thanks.LinksSupport Our Work - https://lsgmedia.net/joinDiscord - https://discord.com/invite/8FmrT9DrvuAcknowledgementsFloyd Frye (Intro/Outro Voice): https://www.tiktok.com/@floydfrye George C Music (Music): https://www.youtube.com/@GeorgeCMusicDisclaimer: This episode features impressions and parodies of celebrities and characters for entertainment purposes only. All impressions are satirical and fictionalized. Clips used in this episode fall under fair use for commentary, criticism, and parody. This is a movie podcast meant purely for entertainment— no affiliation with any celebrities, studios, or rights holders.

Whether you call it Seagram's, LDI, MGP, or its official modern name, Ross & Squibb—the massive facility in Lawrenceburg, Indiana, is the undisputed backbone of the whiskey industry. On this episode, we sit down with Ian Stirsman, the Master Distiller steering the ship at this legendary production powerhouse. We tackle the distillery's endless naming history head-on and trace Ian's journey from a chemical engineer working in a paper mill to commanding one of the largest distillation footprints in the world. Ian delivers a technical masterclass on how they produce massive mash bills at an unbelievable scale, the history behind their iconic 95/5 rye recipe, and why vintage light whiskey is suddenly having a massive moment. Plus, we pull back the curtain on how their team approaches blending, warehouse aging, and wood selection for Ross & Squibb's own rapidly growing premium house brands like George Remus and Rossville Union. Show Notes: Why the industry still calls Ross & Squibb Seagram's, LDI, and MGP Ian Stirsman's journey from chemical engineering to the Lawrenceburg distillery floor The Dayton whiskey bar epiphany that revealed MGP's true market dominance Moving from process engineer to managing a multi-spirit team operation Deconstructing the legendary 95/5 rye recipe and the lasting impact of Seagram's documentation The history of light whiskey and why older expressions are suddenly booming with consumers How the team selects barrels for George Remus and Rossville Union Wood management, rickhouse microclimates, and creating the Remus Experimental Series The future of Ross & Squibb's brand strategy, bottle club, and upcoming changes to the barrel program Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of LIGHT TALK, The Lumen Brothers and Sister welcome Creative Director Melody Tsang and Lighting Designer/Programmer Caleb Franke to the show! Join Caleb, Melody, Ellen, Zac, Steve, and David, as they discuss: The creative and production process for the Elation Lighting Booth show at LDI 2025; Winning the LDI Award; Learning and Programming the Obsidian lighting console; Preparing for "Plan B" changes; A 14 year-old touring with "Thorn"; Learning creative direction at the Parsons School; The new Elation automated lighting fixtures; LILI laser technology; The future of AI in lighting and creative direction; and Wise words of advice for young lighting artists and creative directors. Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

Welcome to Episode 155 of the Think UDL podcast: Accessible Initiatives with Carly Lesoski, Courtney Floyd, and Majo Brito Paez. Carly Lesoski is the Learning Innovation Program Manager at the Dartmouth Center for the Advancement of Learning. Courtney Floyd is a Senior Learning Designer in the Learning Design and Innovation's Learning Lab at Dartmouth and Majo Brito Paez is also a Learning Designer in LDI's Learning Lab at Dartmouth. In today's conversation we will discuss the free and helpful resources that these brilliant minds have produced that we can now all use to help our faculty and staff incorporate UDL into our learning environments, including fantastic case studies that anyone can use for their own trainings on UDL in higher education, so that you are not left reinventing the wheel at your institution. 

Kick off the first episode of 2026 with a fun, draft-style market showdown as host Jeff Malec is joined by David Dziekanski and Zed Francis on The Derivative. Using funky categories and plenty of hot takes, the trio drafts everything from “wait, that's still a thing” trades to market overreactions, false idols, and narratives that didn't survive the year. Along the way, they break down crypto cycles, volatility, cash, and derivatives, mixing sharp insight with dry humor and real debate. It's a loose, fast-paced way to start the year, packed with strong opinions, laughs, and a few bold predictions. SEND IT!Chapters:00:00-02:35= Intro02:36-12:50 = New year reflections, Market Trends and Predictions, Crypto Cycles and The Diminishing importance of Jobs12:51-20:55= Unsophisticated Investment Strategies, Market overactions and consequences & Correlations in the market20:56-35:52= Desensitized to Major Events, Future outlooks, Market Indicators, Volatility Trends & Dogs that didn't Bark - Inflations/Tariffs35:53-43:28= Are We Sure this is Good? The Affordability Crisis and The A.I. Paradox43:29-48:03= Best Meals & Entertainment of 202548:04-59:41= Looking forward: Predictions for 2026From the episode:David on the Derivative: Stacking Assets: Bitcoin, Gold, and the Future of Portfolio Diversification with David Dziekanski of Quantify FundsZed on the Derivative: Protecting the Portfolio not with Long Vol, but with Long Gamma, with ConvexitasThe Polymath Pod: Jason Buck and Zed Francis talk rates, vol, and cheeseburgers?!WTF is LDI, and What's working in Vol Trading with Zed Francis of ConvexitasFollow along on LinkedIn with David and Zed and be sure to check out their websites quantifyfunds.com and convexitas.com for more information!Don't forget to subscribe to⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Derivative⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, follow us on Twitter at⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@rcmAlts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and our host Jeff at⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@AttainCap2⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, or⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠LinkedIn⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ , and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠sign-up for our blog digest⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Disclaimer: This podcast is provided for informational purposes only and should not be relied upon as legal, business, or tax advice. All opinions expressed by podcast participants are solely their own opinions and do not necessarily reflect the opinions of RCM Alternatives, their affiliates, or companies featured. Due to industry regulations, participants on this podcast are instructed not to make specific trade recommendations, nor reference past or potential profits. And listeners are reminded that managed futures, commodity trading, and other alternative investments are complex and carry a risk of substantial losses. As such, they are not suitable for all investors. For more information, visit⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.rcmalternatives.com/disclaimer⁠⁠⁠⁠

In this episode of LIGHT TALK, as part of our Young Designers Series, The Lumen Brothers and Sister interview USITT PAT MacKay Diversity in Design Scholarship Winners Darius Knight Evans and Elena Hewett.   In this episode, Elena, Darius, Ellen, Steve, Dennis, and David discuss: How young designers find the right education; Different paths in discovering lighting design careers; Connecting with the right people in the industry; This years' interesting LDI presentations, panels and products; Exciting innovations; New ideas for post-graduate education; Suggestions for future LDI conferences; The next steps; How young designers are using and dealing with AI and AGI; Coping with stress; and Words of wisdom for other young designers.  Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this Voices episode, the speakers explored LDI—a new organization and framework designed to showcase how data skills and approaches transcend traditional boundaries. They also discussed how leveraging data strategies can unlock value across diverse use cases, driving innovation and adaptability in the legal tech landscape Moderator: Monique Sever, Litigation Support & eDiscovery Supervisor, Harper Grey LLP Speakers: Kelly Friedman, Partner, Heuristica Discovery  Paul Park, Director, Data Breach, Cyber and Data eDiscovery Solutions, BDO

In this episode of LIGHT TALK with The Lumen Brothers pontificate about everything from What We Hope to See at LDI, to 1960's Flashbacks. In this episode, Steve, Dennis, and David discuss: LDI Excitement!; Transferring a production from a proscenium stage to an arena stage; Site Surveys; Feeling the "Vive of the Space"; Finding a path out of the womb; Dancing Mirror Balls; Honey Badgers; New products that we want to see at LDI; "Smaller is Better"; and Listing your references on your resume'. Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

This week Thinking Out Loud with Friends of SoundBroker welcomes Devin Sheets, owner of Alpha Labs who is making waves with their cutting-edge audio software, zero-latency DE-FEEDBACK V1 plugin, which promises to revolutionize live sound by eliminating feedback and room reverb.We'll discuss the development of DE-FEEDBACK, tips, and tricks, and actual hands-on experiences. This your opportunity to ask Devin questions and share your own experiences.AN OPEN CONVERSATION WITH FRIENDS THAT LOVE THE WORLD OF CONCERT AND SPECIAL EVENT PRODUCTIONSJoin our current events support zoomcast show hosted by Jan Landy and his knowledgeable affable panel of friends and colleagues for an entertaining robust discussion offering opinions on anything related to a working professional life in general.Our ZoomCast isn't just a fountain of knowledge; it's also a opportunity to laugh. Think of it as therapy, but with more jokes and fewer couches. Join us and share your thoughts. Stay updated on life and world events, and enjoy multiple good chuckles along the way.

Get an inside look at Elation's most innovative lighting products unveiled at LDI 2025. Explore what's new at Booth #3410, from show-stopping technology to live experiences, and find out how you can access the exhibit with a free pass code.

In this episode of LIGHT TALK with The Lumen Brothers and Sister, as part of our Young Designers Series, interviews lighting designer and Programmer, Rane Renshaw. In this episode, Rane, Ellen, Steve, Dennis, and David discuss: Brackley's Legendary X-Rated Pool Party; Light Talk at LDI Surprise SWAG; The Village People; Designing at the huge nightclubs in Vegas; Rane's beginning his career at the church; The bridge between houses of worship and nightclubs; School days at CMU; "Bob Marley Hope Road" project at The Vanetian; Rane's "The Art of Programming" panels at LDI; "Limelight Wired" education programs; The "Alexa Console"; AI and the future of programing; Are Designer/Programmers the future of lighting?;  and "Being Around". Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this episode of LIGHT TALK, From "The Best of Light Talk", we revisit last year's 7th Annual LIGHT TALK LIVE show from LDI!  The Lumen Family talks about everything from AI Madness to Our Favorite Sandwiches. Join Anne, Steve, Brackley, Zak, Stan, Snoot, and David as they pontificate about: The future of AI in our industry; What will be the relationshop of lighting and video sources in the future regarding output and control; Chapter 7 of "Bobby Danger... The Lighting Guy"; Our favorite lighting fixtures; Our favorite Vegas lighting displays; Zac's Casino heritage; The Neon Museum; Who thought that a Podcast was a good idea; and How do you tell an actor that they continually miss their spike mark? Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this episode of Careers and the Business of Law - Legal Data Intelligence seriese, David Cowen sits down with Odette Claridge (ProSearch), Tara Lawler (Morgan Lewis), and Virginia Ring (Kilpatrick Townsend) to unpack how Legal Data Intelligence (LDI) is transforming mergers, acquisitions, and divestitures. They share how data governance, AI, and collaboration are reshaping due diligence and deal execution and why frameworks like LDI's toolkit are now must-haves for modern legal teams. Key Topics Covered: How LDI's corporate working group built the first data-driven toolkit for M&A and divestitures. Why today's M&A landscape is defined by the 3 Vs of data, volume, variety, and velocity. Practical steps for maintaining data integrity and audit trails across multiple corporate entities. The new reality: collaboration between legal, IT, privacy, and compliance is non-negotiable. How crowdsourcing best practices across firms accelerates learning and innovation. What the Architect Program offers for professionals eager to shape the next wave of legal data frameworks. A look ahead: AI governance and ethical frameworks as the next frontier for legal data professionals.

In this UC Today interview, host Kieran Devlin sits down with Robert Handel, Senior Vice President of Cloud Strategy at LDI, to explore how channel partners can future-proof customer experience strategies. With LDI leveraging Intermedia's Contact Center and AI solutions, the conversation dives into how partners can differentiate, drive measurable outcomes, and position themselves for long-term success in the evolving CX market.AI isn't just a buzzword—it's reshaping the contact center in real, tangible ways. In this in-depth conversation, Robert Handel shares how LDI is using Intermedia's AI-driven contact center tools to improve both customer and agent experiences while delivering new revenue opportunities.Watch the full video to discover:Partner-first strategies: Why Intermedia's business model empowers partners like LDI to lead with customer experience.AI in action: From post-call sentiment analysis to real-time agent assistance, how AI is transforming workflows and training.Measurable outcomes: Case studies where AI-enabled call recording, transcription, and analytics drove customer satisfaction, efficiency, and sales growth.Partner advice: How to approach AI-enabled contact center projects consultatively, avoiding common pitfalls around security and data management.Robert also shares a forward-looking view of where AI is headed in the contact center, highlighting why a consultative, cybersecurity-conscious approach is key for partners looking to succeed.Next Steps:If you're a partner exploring how to differentiate with AI-powered contact center solutions, now is the time to act. Watch the full interview, share your thoughts in the comments, and explore Intermedia's partner resources to learn how you can bring measurable CX improvements to your customers.

In this episode of LIGHT TALK with The Lumen Brothers and Sister, the Lumen family interviews Broadway lighting designer Justin Townsend. In this episode, Justin, Ellen, Steve, and Dennis discuss: Justin's journey as a lighting designer; Teaching hand drafting; Working with Jonathan Groff and Alex Timbers; A trip to Home Depot for Mini 10's; "Bat Boy"; Teaching at NYU; "Here Lies Love"; Collaborating artistically with associates and programmers; Growing up with opera in the house; Playing with light; Staying Dangerous; Being ready to pivot; 48 Dimmers in a Basement; Learning how to work with a large team; Justin's panel at LDI; Challenges of mixing family life with work; and Lessons for young lighting designers of today.   Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this episode of LIGHT TALK, The Lumen Brothers and Sister present their annual Halloween Spectacular! Join Ellen, Dennis, Steve, and David as they pontificate about: What to feed the kiddies; Annoying your neighbors; Planning your display with the right design apporach; What to do when kids start  talking to inflatables; Halloween ghosts projections; Bats in the Belfry; Using haze, smoke, and strobes for maximum effect; The scary power of the Hammond organ; A ladle of seeds; Scary "Tales from Texas"; Being able to afford a Halloween display; and New ideas for LDI swag. Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this UC Today interview, host Kieran Devlin sits down with Robert Handel, Senior Vice President of Cloud Strategy at LDI, to explore how channel partners can future-proof customer experience strategies. With LDI leveraging Intermedia's Contact Center and AI solutions, the conversation dives into how partners can differentiate, drive measurable outcomes, and position themselves for long-term success in the evolving CX market.AI isn't just a buzzword—it's reshaping the contact center in real, tangible ways. In this in-depth conversation, Robert Handel shares how LDI is using Intermedia's AI-driven contact center tools to improve both customer and agent experiences while delivering new revenue opportunities.Watch the full video to discover:Partner-first strategies: Why Intermedia's business model empowers partners like LDI to lead with customer experience.AI in action: From post-call sentiment analysis to real-time agent assistance, how AI is transforming workflows and training.Measurable outcomes: Case studies where AI-enabled call recording, transcription, and analytics drove customer satisfaction, efficiency, and sales growth.Partner advice: How to approach AI-enabled contact center projects consultatively, avoiding common pitfalls around security and data management.Robert also shares a forward-looking view of where AI is headed in the contact center, highlighting why a consultative, cybersecurity-conscious approach is key for partners looking to succeed.Next Steps:If you're a partner exploring how to differentiate with AI-powered contact center solutions, now is the time to act. Watch the full interview, share your thoughts in the comments, and explore Intermedia's partner resources to learn how you can bring measurable CX improvements to your customers.

In this episode of LIGHT TALK with The Lumen Brothers and Sister, as part of our "Emerging Young Artists Series", the Lumen Family interviews Broadway Lighting Designer Colleen Doherty. In this episode, Colleen, Ellen, Steve, Dennis, and David discuss: The Prime Time Emmy cinematography and lighting winners; Trump's Emmy; Starting as a performer in Florida; Undergrad and Graduate School Days; Getting a foothold in New York; Designing "The Twelfth Night Show" and "The Great Emu Wars"; Reliving sleepy productions; Having Don Holder as a mentor; Making the jump to Broadway; Dealing with competition and jealosy; "Comparison is the Death of Joy"; Working with Justin Townsend; Cold-Calling; Working in LORT theatres; Dealing with low fees; The right time to find an agent; Learning how to budget for a freelance career; Colleen's LDI panels; and Advice for young designers heading into the profession. Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this episode of LIGHT TALK with The Lumen Brothers and Sister, the Lumen Family interviews Lighting Entrepreneur and "Geezers of Gear" podcaster Marcel Fairbairn. In this episode, Marcel, Ellen, Steve, Dennis, and David discuss: Being the Poorest guy in Wellington;  GearSource; Musical roots; The "Rock Mass"; Early days at Martin; Crazy parties; PAL 1200 and RoboScan stories; Ticket Bots; Dining with Dinosaurs at LDI; Sin City Sessions; GearShare, Solving cross-rental gear problems with AI; X-Live; Know Your Customer;  Marcel's pandemic Zoom Happy Hours; Are we close to an AI Lighting Console?; and Words of wisdom for young lighting entrepreneurs.  Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

Today in Lighting is sponsored by Pompeo Group, your go-to solution for hiring in lighting, electrical and controls. Hire Brighter. Learn more. Highlights include: Archlight Summit: AI Session New Research Project Spotlights Overlooked PALD Save on LDI 2025 Las Vegas Registration Before October Deadline Embedding the Circular Economy into Luminaires with David Goddard Casambi Debuts at The International Hong Kong Lighting Fair

Ellen Lampert-Greaux is the creative director for Live Design and LDI, an annual conference and trade show for entertainment design and technology professionals. She was on the five-person team that founded LDI in 1988, and has produced the conference and worked on special events for the show since its debut, working on all aspects from programming and promotion to operations, registration, and the attendee experience. She has also produced additional events for the Live Design/LDI franchise such as their Master Classes series for lighting, projection, audio, scenic design; the Envision Symposium; Backstage Las Vegas; and XLIVExLDI. She is also a triple award-winning writer - editor for Live Design (FOLIO: EDDY Award in 2021, 2022, and 2023) who specializes in entertainment design and technology, writing regularly for livedesignonline.com, as well as a freelance writer on technology and architectural lighting. She is also a co-host ( a Lumen sister) on the Light Talk podcast.She attended NYU where she was an English major, and Temple University for a BFA in television/film production. She earned her MFA in arts administration from Brooklyn College and was the publicity director of the Brooklyn Academy of Music (1979-1986). She is a theatrical press agent and a member of ATPAM/IATSE, as well co-founder in 1996 and co-director of the St. Barth Film Festival in the French West Indies, having run a similar festival in Avignon, France (1984-1993). She speaks fluent French and translates articles for magazines from French to English. This conversation explores the evolution and impact of LDI since its inception in 1988, highlighting the commitment of Light Switch to enhance experiences through design. The discussion covers various training opportunities, innovative events, and the importance of inclusivity and networking within the entertainment industry. The future of LDI is also addressed, emphasizing its role in fostering mentorship and professional growth.This Episode is brought to you by Lightswitch

The great experiment begins! Join me as I try growing tomatoes indoors all year long, aiming for a weekly harvest. Can I pull it off? What problems will I encounter? How will they be solved? video reviewing grow tent and light: https://youtu.be/WCzt-nkAPVovideo for gravity-fed watering system: https://youtu.be/2LJJxQ3L8h4Article on PPM: https://www.gardenmyths.com/calculating-the-ppm-of-nitrogen-in-your-fertilizer/PPM Calculator: https://www.gardenmyths.com/fertilizer-ppm-calculator/Article on LDI: https://www.gardenmyths.com/what-is-dli-the-daily-light-integral/Video on 'Purple' tomato: https://youtu.be/KGWEZ7HxTEMVideo on Best DLI for Tomatoes: https://youtu.be/zNhIQbynl9ISpider Farmer gravity-fed watering system (affiliate links):From Amazon USA: https://amzn.to/4fgOewqFrom Amazon Canada: https://amzn.to/45mnFBySpider Farmer tent (affiliate links):From Amazon USA: https://amzn.to/4fsgTi6From Amazon Canada: https://amzn.to/4myGI2rSpider Farmer LED light (affiliate links)From Amazon USA: https://amzn.to/3HqC3AIFrom Amazon Canada: https://amzn.to/4fy25i4Contact Spider Fermer for pricing details. USA(global): https://spider-farmer.com Canada: https://spiderfarmer.ca Europe: https://spiderfarmer.eu UK: https://spiderfarmer.co.uk Australia: https://spiderfarmer.com.au Thailand: https://spiderfarmer-th.com Amazon-US: https://amazon.com/spiderfarmer Amazon-EU: https://amazon.de/spiderfarmer----------------------------------------------------------- Spider Farmer G3000 Light:https://www.amazon.com/stores/page/99FCDD73-E1CF-4369-8F4B-368A26EF287D Spider Farmer Self-Watering System:Advertiser Signature: Influencer Signature: IIIhttps://www.amazon.com/Spider-Farmer-Gravity-Fed-Self-Watering-Reservoir/dp/B0DFYM875M?ref_=ast_sto_dp Spider Farmer Grow Tent:https://www.amazon.com/dp/B083K7TWDR?maas=maas_adg_9B7AA9EE2E5B508C718945703A9635D8_afap_abs&ref_=aa_maas&tag=maas

In this episode of LIGHT TALK, The Lumen Brothers and Sister talk about everything from Rising  Vectorworks Prices to Dennis' Lighting Injustices. Join Ellen, Dennis, Steve, and David as they pontificate about: Dancing in the Dark; The new Sphere Wizard of Oz show; Extensive uses of Gobos; Creating a stained glass look on a window; Paying attention to the playwrights' lighting notes; Designing the black before you design the light; Our most powerful blackouts; The new inflation barometer; Dennis' strange Dunkin Donuts encounter at LDI; Are software subscriptions here to stay?; Vectorworks' new pricing strategy; Kit fees; and Wasting time at technical rehearsals. Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this episode of LIGHT TALK, The Lumen Brothers and Sister talk about everything from Being Attracted to Triangles to The Village People. Join Ellen, Zac, and David as they pontificate about: New time for "Light Talk at LDI"; Zac's new appointment as one of USITT's Digital Media Commissioners; Making the world safer for projections; Lighting Zones; Odds vs. Evens; Striving for a "Hot Center"; Designing for heat and hail storms at summer festivals; "The HAL 2001 AI Lighting Console"; Can the design process be standardized?; Favored Nations and negotiating design fees; Having the flexibility to adhere to other artists' standards; "Test and Adjust"; The "Zac-App"; David's Memoirs; and "Freezing" Shows.  Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this powerful episode of the TIck Boot Camp Podcast, Dr. Jaquel Patterson, nationally recognized naturopathic physician and medical director of Fairfield Family Health, joins Matt Sabatello to explore the many layers of Lyme disease recovery – from hidden mold exposure to hormone balance and mental health support. Mold & Lyme Disease – Why mold toxicity can block Lyme recovery and how Dr. Patterson stages treatment so patients don't get overwhelmed. Hormone Health – The vital role hormones play in energy, mood, joint health, and the ability to fight chronic infections. Mental Health & Lyme – How inflammation impacts the brain, leading to panic attacks, anxiety, depression, and brain fog — and how those symptoms can reverse with healing. Low Dose Immunotherapy (LDI) – What it is, how it retrains the immune system to stop overreacting, and why it's helping Lyme patients stabilize. Inflammation & Flares – Practical tools like turmeric, hydration, and electrolytes to calm Herxheimer reactions and ease painful flare days. Environmental Toxins – How pesticides, polluted air, and contaminated water add to the burden — and realistic steps to reduce exposure.

In this lively on-location episode of The Collective Us, hosts Erica Austin and Ryan Buck attend the Michigan Community Action (MCA) Summer Conference in Grand Rapids. They speak with attendees, leaders, and partners to highlight the conference's sessions, energy, and impact on Michigan's Community Action Network.Brian McGrain, MCA Executive Director, explains that the conference blends inspiration, education, and networking. It helps staff from Michigan's 27 Community Action Agencies connect, recharge, and learn from one another.Sessions include organizational guidance, new funding and reporting practices, leadership development, and even wellness offerings like yoga at dawn.The conference balances 14+ hour days with reflection time, celebrating staff while addressing the emotional toll of front-line service work.Speaker Shannon Cohen emphasized “replenishment” over self-care—reminding staff to refuel emotionally to better serve others.The message resonated across the conference, affirming the importance of caring for the caregiver.Rebecca Kraus, longtime LDI instructor, discussed the nine-month program designed to build leadership capacity for emerging and mid-level managers.LDI focuses on communication, behavioral dynamics, and personal coaching. Peer learning and one-on-one mentorship are critical.Kraus is stepping down, with Stephanie Kasprzak (program co-founder) and Michelle Stevens taking over and enhancing the curriculum to align with Emerging Leaders and the national CCAP certification.The training path is intentionally designed to cultivate future leaders. Many executive directors across Michigan have gone through LDI.Stevens and Kasprzak emphasized inclusive design, peer support, and reducing the learning curve for young leaders.Gustavo Perez, Director of Kent County Community Action, described this year's service project: decorating food boxes with uplifting artwork.The goal is to bring smiles and messages of hope to struggling families. Volunteers found joy and purpose in contributing creatively.Attendees shared key takeaways:AI's role in community action.Leadership skills and mental health in the workplace.Innovative programs like OLSA's “Rx Kids,” offering new moms $1,500 to use freely.Relationship-building and peer support were among the most appreciated elements.Attendees suggested songs like "Can't Stop the Feeling" by Justin Timberlake and "Stayin' Alive" by the Bee Gees—highlighting the conference's vibrant, uplifting energy.MCA and conference participants stressed that Community Action is more than service—it's a movement powered by hope, data, and shared mission.Erica and Ryan encourage donations to local community action agencies and invite listeners to share the podcast to spread awareness.Three Words to Sum It All Up?Innovative. Inspiring. Engaging.

FMF YouTube: https://www.youtube.com/@funmedFMI Center for Optimal HealthWebsite: fmioptimal.comInstagram: @fmioptimalFunctional Medicine of Idaho:Website: funmedidaho.comInstagram: @funmedidahoWe provide the highest quality supplements with responsible sourcing and the utmost commitment to purity funmedshop.com + more resources on IG: @funmedfoundations

Our analysts Andrew Sheets and Aron Becker explain why European credit markets' performance for the rest of 2025 could be tied to U.S. growth. Read more insights from Morgan Stanley.----- Transcript -----Andrew Sheets: Welcome to Thoughts on the Market. I'm Andrew Sheets, Head of Corporate Credit Research at Morgan Stanley.Aron Becker: And I'm Aron Becker, Head of European Credit Strategy.Andrew Sheets: And today on the program, we're continuing a series of conversations covering the outlook for credit around the world. Morgan Stanley has recently updated its forecast for the next 12 months, and here we're going to bring you the latest views on what matters for European credit.It's Thursday, June 12th at 2pm in London.So, Aron, it's great to have this conversation with you. Today we're going to be talking about the European credit outlook. We talked with our colleague Vishwas in the other week about the U.S. credit outlook. But let's really dive into Europe and how that looks from the perspective of a credit investor.And maybe the place to start is, from your perspective, how do you see the economic backdrop in Europe, and what do you think that means for credit?Aron Becker: Right. So, on the European side, our growth expectations remain somewhat more challenging. Our economists are expecting growth after a fairly strong start to slow down in the back half of this year. The German fiscal package that was announced earlier this year will take time to lift growth further out in 2026. So, in the near term, we see a softening backdrop for the domestic economy.But I think what's important to emphasize here is that U.S. growth, as Vishwas and you have talked about last time around, is also set to decelerate on our economists forecast more meaningfully. And that matters for Europe.Two reasons why I think the U.S. growth outlook matters for European credit. One, nearly a quarter of European companies' revenues are generated in the U.S. And two, U.S. companies themselves have been very actively tapping the European corporate bond markets. And in fact, if you look at the outstanding notion of bonds in the euro benchmarks, the largest country by far is U.S. issuers. And so, I do think that we need to think about the outlook on the macro side, more in a global perspective, when we think about the outlook for European credit. And if we look at history, what we can deduct from the simple correlation between growth and credit spreads is current credit valuations imply growth would be around 3 percent. And that's a stark contrast to our economists' forecast where both Europe and U.S. is decelerating to below 1 percent over the next 12 months.Andrew Sheets: But Aron, you know, you talked about the slow growth, here in Europe. You talked about a slower growth picture in the U.S. You talked about, you know, pretty extensive exposure of European companies into the U.S. story. All of which sound like pretty challenging things. And yet, if one looks at your forecasts for credit spreads, we think they remain relatively tight, especially in investment grade.So, how does one square that? What's driving what might look like, kind of, a more optimistic forecast picture despite those macro challenges?Aron Becker: Right. That's a very important question. I think that it's not all about the growth, and there are a number of factors that I think can alleviate the pressures from the macro side. The first is that unlike in the U.S., in Europe we are expecting inflation to decelerate more meaningfully over the coming year. And we do think that the ECB and the Bank of England will continue to ease policy. That's good for the economy and the eventual rebound. And we also think that it's good for demand for credit products. For yield buyers where the cash alternative is getting less and less compelling, I think they will see yields on corporate credit much more attractive. And I do think that credit yields right now in Europe are actually quite attractive.Andrew Sheets: So, Aron, you know, another question I had is, if you think about some of those dynamics. The fact that interest rates are above where they've been over the last 10 years. You think about a growth environment in Europe, which is; it's not a recession, but growth is, kind of, 1 percent or a little bit below.I mean, some ways this is very similar to the dynamic we had last year. So, what do you think is similar and what do you think is different, in terms of how investors should think about, say, the next 12 months – versus where we've been?Aron Becker: Right. So, what's really similar is, for example, the yield, like I just mentioned. I think the yield is attractive. That hasn't really changed over the past 12 months. If you just think about credit as a carry product, you're still getting around between 3-3.5 percent on an IG corporate bond today.What's really different is that over the same period, the ECB has already lowered front-end rates by 200 basis points. And at the same time, if you think about the fiscal developments in Germany or broader rates dynamics, we've seen a sharp steepening of yield curves; and curves are actually at the steepest levels in two years now. And what this leaves us with is not only high carry from the yield on corporate bonds, but also investors are now rolling down on a much steeper curve if they buy bonds today, especially further out the curve.So, by our estimate, if you aggregate the two figures in terms of your expected total return, credit offers actually total returns much higher than over the past 12 months, and closer to where we were in the LDI crisis in 2022.Andrew Sheets: So, Aron, another development I wanted to ask you about is, if you look at our forecast for the year ahead, our global forecast. One theme is that on the government side there's projected to be a lot more borrowing. There's more borrowing in Germany, and then there's more borrowing in the U.S., especially under certain versions of the current budget proposals being debated. So, you know, it does seem like you have this contrast between more borrowing and kind of a worsening fiscal picture in governments, a better fiscal picture among corporates. We talk about the spread. The spread is the difference between that corporate and government borrowing.So, I guess looking forward first, do you think European companies are going to be borrowing more money? And certainly more money on a relative, incremental basis at these yield levels, which are higher than what they're used to in the past. And, secondly, how do you think about the relative valuation of European credit versus some of the sovereign issuers in Europe, which is often a debate that we'll have with investors?Aron Becker: Big picture? We have seen companies be very active in tapping the corporate bond markets this year. We had a record issuance in May in terms of supply. Now I would push back on the view that that's negative for investors, and expectations for spreads to widen as a result for a number of reasons. One is a lot of gross issuance tends to be good for investors who want to pick up some new issue premiums – as these new bonds do come a little bit cheap to what's out there in terms of available secondary bonds.And second, it creates a lot of liquidity for investors to actually deploy capital, when they do want to enter the bond market to invest. And what we really need to remember here is all this strong issuance activity is coming against very high maturing, volumes of bonds. Redemptions this year are rising by close to 20 percent versus last year. And so, even though we are projecting this year to be a record year for growth issuance from investment grade companies, we think net supply will be lower year-on-year as a result of those elevated, maturities.So overall, I think that's going to be a fairly positive technical backdrop. And as you alluded to it, that's a stark contrast to what the sovereign market is facing at the moment.Andrew Sheets: So, on that net basis, on the amount that they're issuing relative to what they're paying back, that actually is probably looking lower than last year, on your numbers.Aron Becker: Exactly.Andrew Sheets: And finally, Aron, you know, so we've talked a bit about the market dynamics, we've talked about the economic backdrop, we've talked about the issuance backdrop. Where does this leave your thoughts for investors? What do you think looks, kind of, most attractive for those who are looking at the European credit space?Aron Becker: Opportunities are abound, but I think you need to be quite selective of where to actually increase your risk exposure, in my view. One part which we are quite out of consensus on here at Morgan Stanley is our recommendation in European credit to extend duration further out the curve.This goes back to the point I made earlier, that curves are very steep and a lot of that carry and roll down that I think look particularly attractive; you do need to extend duration for that. But there are a number of reasons why I think that that type of trade can work in this backdrop.For one, like I said, valuations are attractive. Two, I also think that from an issuer perspective, it is expensive to tap very long dated bonds now because of that yield dynamic, and I don't necessarily see a lot of supply coming through further out the curve. Three, our rates team do expect curves to bull steepen on the rate side and historically that has tended to favor excess returns further out the curve.And fourth is, a word we love to throw around – convexity. Cash prices further out the curve are very low in investment grade credit. That tends to be actually quite attractive because then even if you get the name wrong, for example, and there are some credit challenges down the line for some of these issuers, your loss given default may be more muted if you entered the bond at a lower cash price.Andrew Sheets: Aron, thanks for taking the time to talk.Aron Becker: Thanks, Andrew. Andrew Sheets: And to our listeners, thank you for sharing a few minutes of your day with us. If you enjoy the show, leave us a review wherever you listen to this podcast and share Thoughts on the Market with a friend or colleague today.

In this episode of LIGHT TALK, The Lumen Brothers talk about everything from Annoying Assistant Directors, to the "LDI 2025 Light Talk After Dark Party". Join Dennis, Steve, and David as they pontificate about: Making sure Snoot is happy; Sister Ellen having fun at Showlight; National Design Portfolio Review and Design Showcase West; Classes you should take and other opportunities to learn broadcast lighting design; Balancing artistic aspirations with real world budgets; "5 Guys"; "Have-a-Bisquit Sampler"; A Fuzzy Brick of Bliss; "Lighting Design and the Art of Problem Solving"; The Light Talk Puzzler answer; Zen and the Art of Lighting Design; How to best explain to a young lighting designer that their light cue has no purpose; and Lee Watson's Bow Ties. Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

As trade tensions, uncertainty over the direction of interest rates, and pension reforms reshape the investment landscape, liability-driven investing (LDI) may provide a source of stability. In this episode, Jeffrey Dissmann, who leads Mercer's Investments business in Germany, is joined by Sheena Frost, Lead of the Europe ex-UK Portfolio Management Solutions Team at Mercer and Rik Klerkx, Chief Investment Officer LDI and Private Markets at Cardano Netherlands, to discuss how investors across Europe are adapting their LDI strategies.The discussion spans regulatory variations, the resurgence of bonds, inflation hedging challenges, and the operational plumbing that may facilitate resilient portfolios. Together, they examine the trade-offs between swaps and sovereign bonds, the growing role of private assets, and lessons learned from the UK's LDI crisis. This podcast contains statements on historical performance which may not be repeated in the future. Please note that returns on investments are not guaranteed.This content is for institutional investors and for information purposes only. It does not contain investment, financial, legal, tax or any other advice and should not be relied upon for this purpose. The materials are not tailored to your particular personal and/or financial situation. If you require advice based on your specific circumstances, you should contact a professional adviser. Opinions expressed are those of the speakers as of the date of the recording, are subject to change without notice and do not necessarily reflect Mercer's opinions.This does not constitute an offer or a solicitation of an offer to buy or sell securities, commodities and/or any other financial instruments or products or constitute a solicitation on behalf of any of the investment managers, their affiliates. For the avoidance of doubt, this is not formal investment advice to allow any party to transact. Additional advice will be required in advance of entering into any contract.Read our full important notices - click here

Shifts in interest rates have thrust Liability-Driven Investing (LDI) into the spotlight, reshaping pension plan liabilities and presenting new de-risking opportunities. This episode of the All the Credit® Credit Markets in Transition sub-series examines impacts on funded status, plan sponsor adaptations, and the interplay of structured products and derivatives in portfolio construction. PGIM Fixed Income's Brian Barnhurst, CFA, Head of Global Credit Research, hosts Tom McCartan, FIA, CFA, Multi-Sector Portfolio Manager. Recorded on March 27, 2025.

In this podcast panel discussion, the speakers provided an introductory discussion on LDI and its impact on how data is reviewed, analyzed and used to identify relationship trends.   Moderator: @Ravan Roddy - eDiscovery Manager, Zoetis   Panelists: @Chris Acosta - Director, eDiscovery Resources, Morrison Foerster @Carl Morrison -  Senior Manager, Legal Operations, Otsuka Pharmaceutical Companies (U.S.) Recorded 3-14-2025

Outpatient Low-Dose Initiation of Buprenorphine for People Using Fentanyl JAMA Network Open The accumulation of fentanyl in fat is likely responsible for the risk of precipitated withdrawal when buprenorphine is initiated. Low dose initiation (LDI) of buprenorphine attempts to minimize this risk. This retrospective study included 126 individuals making 175 LDI attempts in an outpatient setting. Patients chose either a 4 day or 7 day LDI protocol with buprenorphine monoproduct. Both protocols begin with buprenorphine 0.5mg, increasing to 8mg tid. Overall LDI was successful in 34% of attempts (with no difference between the protocols) and one month retention on buprenorphine was 21%. Repeated LDI attempts were less likely to be successful (second attempt aOR 0.3). Unhoused people had lower odds of success (OR 0.4). The authors conclude that people with OUD using fentanyl attempting outpatient LDI of buprenorphine had low odds of success.   Read this issue of the ASAM Weekly Subscribe to the ASAM Weekly Visit ASAM

Episode Description: In this episode, David Cowen speaks with Bobby Malhotra, Partner at Winston & Strawn and a founding member of Legal Data Intelligence (LDI). Together, they explore how AI, eDiscovery, and data governance are reshaping the legal industry. Bobby also highlights the power of mentorship, the evolution of legal data intelligence, and the lessons he's learned from his own career journey. If you're navigating the future of law, this conversation is a must-listen. What's Inside? eDiscovery's Next Chapter: Bobby dives into how the field has evolved from email production to a sophisticated practice that influences case outcomes and strategies. The Role of AI in Legal Data: Discover how conversational AI is eliminating friction, accelerating time to insights, and revolutionizing how legal teams manage data. Legal Data Intelligence (LDI): Learn about the founding and mission of LDI, a professional network designed to tackle the most complex data challenges across disputes, transactions, and compliance. Mentorship and Leadership: Bobby shares how mentorship transformed his career and why building relationships with mentors and mentees is critical to success in the legal profession. Going Above and Beyond: Bobby recommends Unreasonable Hospitality by Will Guidara as a blueprint for creating extraordinary client experiences. Key Mentions: Books: Unreasonable Hospitality by Will Guidara Influencers: Kathleen McDowell, John Rosenthal, and Scott Cohen Organizations: Legal Data Intelligence (LDI), and  Winston & Strawn Takeaways Leverage AI Tools: Start using conversational AI like ChatGPT to interrogate your data and uncover insights faster. Mentorship Matters: Find mentors who align with your goals and reciprocate by sharing your own expertise. Join Professional Networks: Get involved with groups like LDI to connect with industry leaders and stay ahead of emerging trends.

Mike, Kody, Christian, and Gareth are back chatting about a few different dual motor projects, Canadian tech support, LDI, a few different tangents, and recapping 2024.

In this episode of LIGHT TALK, The Lumen Brothers discuss everything from Surviving LDI to MFA Programs to Avoid. Join David, Stan, and Steve as they pontificate about: The LDI Awards; Our LDI most interesting products reports; Vari*Lite's hidden booth with "The Hive"; How to budget resources for a production; Wearing multiple hats at a lighting production company; How to handle work that you might not be qualified to do; "Las Vegas LDI Convention Mites";  How American MFA lighting programs are failing to prepare lighting students for the profession; and, Is lighting equipment becoming too complex? Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this episode, David Cowen dives into the transformative role of Legal Data Intelligence (LDI) with industry leaders Julia Hasenzahl, Jeremiah Weasenforth, and Ashley Christakis. They discuss how meta-skills like strategic thinking and adaptability are reshaping legal operations and explore how experiential knowledge is driving predictive insights across the legal ecosystem. Key Topics: Meta-Skills Matter: Why adaptability, curiosity, and problem-spotting are essential for thriving in LDI. Expanding Roles: How LDI professionals are integrating e-discovery, governance, privacy, and risk management. Building Talent: The importance of fostering a culture of radical thinking to attract top talent in a competitive market. Better vs. Different: The dual need to improve current processes while rethinking how legal data is used to create predictive strategies. Meet the Guests: Julia Hasenzahl : Co-founder and CEO of ProSearch, a leader in applying data intelligence to legal operations and e-discovery. Jeremiah Weasenforth: Legal Analytics Director at Edward Jones, pioneering data-driven approaches to legal strategy. Ashley Christakis: Senior Manager eDiscovery and Legal Operations at CrowdStrike, innovating the intersection of e-discovery and operational excellence. Subscribe and Share: Catch every episode of Careers in the Business of Law on Apple Podcasts, Spotify, or wherever you listen. Take your career from now to next. Never eat alone.

In this episode of LIGHT TALK, The Lumen Brothers (and Sisters) present their 7th Annual LIGHT TALK LIVE show from LDI!  The Lumen Family talks about everything from AI Madness to Our Favorite Sandwiches. Join Anne, Steve, Brackley, Zak, Stan, Snoot, and David as they pontificate about: The future of AI in our industry; What will be the relationshop of lighting and video sources in the future regarding output and control; Chapter 7 of "Bobby Danger... The Lighting Guy"; Our favorite lighting fixtures; Our favorite Vegas lighting displays; Zac's Casino heritage; The Neon Museum; Who thought that a Podcast was a good idea; and How do you tell an actor that they continually miss their spike mark? Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.  

In this episode of LIGHT TALK, The Lumen Brothers discuss everything from Time Warps to Bette Midler. Join David, Stan, and Steve as they pontificate about: Our big Light Talk celebration at LDI; Does it make sense to retrofit old Source 4's with Source 4WRD's?; Using AI and Chat GPT in Projects; When is a design finished; Freezing a show; "The Perfectionism Trap"; Bad Hombre Productions' "The Mist Liquid Hydrogen Fogger"; Our Dream products for LDI; What to do with a professor who is a Jerk; and Stan's Valley Girl impersonation.   Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this episode of LIGHT TALK, The Lumen Brothers discuss everything from Horrible Programmers, to "Mr. Midnight". Join David, Stan, and Steve as they pontificate about: What to do when your show sucks; Scar Tissue; "The Endpoint Effect"; Respecting and researching other cultures when you design a show; "Blue Hawaii"; What to do when your programmer disappears; Stan becoming "Tom from CarTalk"; "Evil Kitten Clothing for Stagehands"; Stan's collection of Bowties; Escaping the madness; Standing your ground and fight for your students; "The Prime Directive" in education; Ignoring the background noise; LDI daily routines.; and What new technology will be at LDI. Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this episode of LIGHT TALK, The Lumen Brothers and Sister welcome lighting designer Manny Treeson to the show. Join Manny, Ellen, Stan, Brackley, and David as they pontificate about: The ongoing search for LDI Swag;  Episode 1 of "Great Failures of Artificial Intelligence"; Manny's journey as a lighting designer; Grad school at Carnegie Mellon; NYX Design; Disney Days; Designing with Generative Content; Working with Notch; More thoughts on The Sphere; The challenges of designing large-scale corporate shows; Designing Movie Premiers; Sequeing into architectural lighting; Most challenging projects; Manny's LDI panel; and Wise advice for young lighting designers. Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this episode of LIGHT TALK, The Lumen Brothers and Sister welcome lighting designer Michael Stiller to the show. Join Michael, Ellen, David, and Steve as they pontificate about: Becoming a lighting designer without any formal training in the field; Bard College; Finding gigs in New York City; Media and generative driven lighting; Experiential lighting; How disruptive will AI be to the architectural lighting world; Where design ideas come from; Combining pixels with lumens; Element Labs; "A gentle blast of wind"; Thoughts about The Sphere; "A Place for In Your Face"; Teaching lighting design to non-lighting designers; Do architects understand lighting design?; Michael's "Breaking Rectangles" session at LDI; Advice for young designers who want to get involved in large scale architectural lighting design; and How to talk about light. Nothing is Taboo, Nothing is Sacred, and Very Little Makes Sense.

In this Episode of The Bourbon Life Podcast, presented by Liquor Barn, Mark is flying solo and hanging out in The Bourbon Life Studio with Amir Peay, Owner and Operator of James E. Pepper Distilling Co. Amir was previously a guest on Episodes 106 and 212. Mark talks with Amir about what's been going on with the Distillery and the brand since he was last on the show in March of this year, the advantages of being located in beautiful Lexington, Kentucky and why people need to make Lexington their home base on their Kentucky Bourbon Trial visit, the current state of the Bourbon market and where Amir thinks things might be headed based on recent statistics and news reports, as well as some exciting things that are on the horizon for the Distillery and the brand. They also taste and review a 15-Year Old James E. Pepper 1776 Rye (which was one of the earliest releases ever from the Distillery sourced from the old LDI), their James E. Pepper Barrel Proof Decanter Bourbon, and a James E. Pepper Single Barrel Bourbon. This Episode of The Bourbon Life Podcast is presented by Liquor Barn and is also sponsored by Penelope Bourbon, Limestone Farms Bourbon, VisitLEX, Old Dominick, Three Chord Bourbon, James E. Pepper Distillery, Pappy & Co, and The Kitchen Table at James B. Beam Distilling Co. Check out all of our amazing sponsors online at:  www.liquorbarn.com  www.penelopebourbon.com www.limestonefarms.com www.visitlex.com       www.olddominick.com              www.threechordbourbon.com www.jamesepepper.com   www.pappyco.com www.visitthekitchentable.com

Mark Asaro is the Chief Investment Officer of Noble Wealth Management, an RIA based out of Colorado that oversees $320 million in assets under management for 160 households. Mark stands out with his liability-driven investing approach, which builds retirement portfolios focused on managing sequence of return risk, leveraging the use of closed-end bond funds to generate income to cover client expenses during the critical early retirement years. Listen in as Mark shares how Liability-Driven Investing (LDI) matches retirement portfolios to client spending needs, securing early retirement finances through strategically allocated fixed income to generate income and equity to manage inflation risk. He dives into his tactical approach to rebalancing portfolios, using market conditions to optimize asset allocations between equities and bonds. Mark also reflects on his firm's strategic shift during the 2022 market downturn, when it capitalized on high bond yields, why he believes investment management isn't a commodity, and how the LDI approach ultimately supports clients' long-term financial stability and peace of mind. For show notes and more visit: https://www.kitces.com/407

David Eichhorn is the CEO and Head of Investment Strategies at NISA, a $400 billion employee-owned asset manager of risk-controlled fixed income and derivative overlays that is widely respected for its highly collaborative client relationships. The firm is one of the largest derivative overlay managers in the world and the largest U.S. manager of LDI strategies. Our conversation dives into Dave's twenty-five years at NISA, its client-centric focus, approach across fixed income and derivative strategies, culture, and opportunities and risks in the markets. Learn More Follow Ted on Twitter at @tseides or LinkedIn Subscribe to the mailing list Access Transcript with Premium Membership

In this episode of my Freight Broker Boot Camp, I share a story a few years back after I started my freight brokerage in 2003 and a friend of mine said something that at first upsets me and then I realized why. He said, "Dennis just got lucky with LDi. It was just good timing". Learn what I did